Company database
Boehringer Ingelheim Therapeutics GmbH
Labor Dr. Merk & Kollegen GmbH (LMK) was founded in 1971 and holds excellent expertise in biosafety testing for virology, microbiology, cell based bioassays and toxicity from pharmaceutical industries or medical device manufacturers. A wide range of GMP and GLP compliant methods for preclinical and clinical studies or quality control of final product testing is available.
Final release testing and stability testing of veterinary vaccines is an additional service for pharmaceutical industries.
Validation of manufacturing process steps for virus elimination or inactivation, testing of substances for antiviral activity or extraneous agent testing of materials of animal or cell culture origin are available with a broad range of human or animal pathogenic virus/cell systems.
Since 2005, as member of the expert committee “virus disinfection” of the DVV (German Association for the Control of Virus Diseases) and the DIN, LMK offers antiviral efficacy testing of disinfectants for human and veterinary use.
LMK cooperates with companies, universities and research institutions to generate expert experience and exchange of know-how. With our well experienced team we are prepared to meet the customers‘ needs with appropriate and innovative solutions.
Biotech Companies, Pharmaceutical Companies, Medtech Companies, In-vitro Diagnostics, Analytics, Proteins/Peptides, Contract Manufacturing/OEM, Biotech Services, Contract Research & Development, Microbiology, Cells/Cell Lines, Production Organisms, Diagnostics, Laboratory Supplies/Reagents
Further information on the websites of BIOPRO Baden-Württemberg:
